Insulin glargine: a new basal insulin analogue
- PMID: 12391389
- DOI: 10.1093/qjmed/95.11.757
Insulin glargine: a new basal insulin analogue
Similar articles
-
Insulin detemir (levemir), a new long-acting insulin.Med Lett Drugs Ther. 2006 Jul 3;48(1238):54-5. Med Lett Drugs Ther. 2006. PMID: 16841022
-
Comparative trial between insulin glargine and NPH insulin in children and adolescents with type 1 diabetes.Diabetes Care. 2001 Nov;24(11):2005-6. doi: 10.2337/diacare.24.11.2005. Diabetes Care. 2001. PMID: 11679478 Clinical Trial. No abstract available.
-
Insulin glargine clinical trials.Clin Ther. 2004 Jul;26(7):1179-81; discussion 1182-3. doi: 10.1016/s0149-2918(04)90190-7. Clin Ther. 2004. PMID: 15336483 Review. No abstract available.
-
Insulin glargine: commentary on the duration of action and lower risk of nocturnal hypoglycaemia in patients with diabetes.Expert Opin Pharmacother. 2004 Jan;5(1):1-2; author reply 2-3. doi: 10.1517/14656566.5.1.1. Expert Opin Pharmacother. 2004. PMID: 14680430 No abstract available.
-
Long-Acting Basal Insulins: A Review of the More Recently Approved Agents.Cardiol Rev. 2019 Sep/Oct;27(5):260-266. doi: 10.1097/CRD.0000000000000266. Cardiol Rev. 2019. PMID: 31393288 Review.
Cited by
-
Evolving approaches to intensive insulin therapy in type 1 diabetes: multiple daily injections, insulin pumps and new methods of monitoring.Rev Endocr Metab Disord. 2003 Dec;4(4):325-34. doi: 10.1023/a:1027345927676. Rev Endocr Metab Disord. 2003. PMID: 14618017 Review. No abstract available.
-
Insight into human insulin aggregation revisited using NMR derived translational diffusion parameters.J Biomol NMR. 2018 Jun;71(2):101-114. doi: 10.1007/s10858-018-0197-y. Epub 2018 Jun 12. J Biomol NMR. 2018. PMID: 29948440
-
Insulin glargine effectively achieves glycemic control and improves insulin resistance in patients with early type 2 diabetes that exhibit a high risk for cardiovascular disease.Exp Ther Med. 2014 Jul;8(1):147-152. doi: 10.3892/etm.2014.1688. Epub 2014 Apr 24. Exp Ther Med. 2014. PMID: 24944613 Free PMC article.
-
Recombinant A22(G)-B31 (R)-human insulin. A22 addition introduces conformational mobility in B chain C-terminus.J Biomol NMR. 2012 Apr;52(4):365-70. doi: 10.1007/s10858-012-9612-y. Epub 2012 Feb 14. J Biomol NMR. 2012. PMID: 22350952 No abstract available.
-
Systemically modeling the dynamics of plasma insulin in subcutaneous injection of insulin analogues for type 1 diabetes.Math Biosci Eng. 2009 Jan;6(1):41-58. doi: 10.3934/mbe.2009.6.41. Math Biosci Eng. 2009. PMID: 19292507 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical